{
    "organizations": [],
    "uuid": "542cc6d859c4194891a15c287cac6d96faae576a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-neptune-technologies-announces-res/brief-neptune-technologies-announces-research-agreement-aimed-at-medical-cannabinoid-based-products-idUSFWN1PE0JF",
    "ord_in_thread": 0,
    "title": "BRIEF-Neptune Technologies Announces Research Agreement Aimed At Medical Cannabinoid-Based Products",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 19 (Reuters) - Neptune Technologies & Bioressources Inc :\n* NEPTUNE ANNOUNCES RESEARCH AGREEMENT AIMED AT NEW MEDICAL AND WELLNESS CANNABINOID-BASED PRODUCTS\n* NEPTUNE TECHNOLOGIES & BIORESSOURCES-ANNOUNCED EXCLUSIVE RESEARCH AGREEMENT FOR DEVELOPING NEW MEDICAL, WELLNESS TARGETED CANNABINOID-BASED PRODUCTS​\n* NEPTUNE TECHNOLOGIES & BIORESSOURCES INC - ‍ REACHED THE EXCLUSIVE RESEARCH AGREEMENT WITH A KRILL OIL PROVIDER​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-19T21:20:00.000+02:00",
    "crawled": "2018-01-20T17:51:08.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "neptune",
        "technology",
        "bioressources",
        "inc",
        "neptune",
        "announces",
        "research",
        "agreement",
        "aimed",
        "new",
        "medical",
        "wellness",
        "product",
        "neptune",
        "technology",
        "exclusive",
        "research",
        "agreement",
        "developing",
        "new",
        "medical",
        "wellness",
        "targeted",
        "neptune",
        "technology",
        "bioressources",
        "inc",
        "reached",
        "exclusive",
        "research",
        "agreement",
        "krill",
        "oil",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}